http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#Head http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#assertion http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#provenance http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#pubinfo http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#assertion http://purl.obolibrary.org/obo/DOID_10763 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_10763 http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00701 http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#association http://www.w3.org/2000/01/rdf-schema#label "* [see Drug Interactions ( 7 12.3 * LEXIVA is contraindicated when coadministered with the following drugs: o Alpha 1-adrenoreceptor antagonist: Alfuzosin o Antiarrhythmics: Flecainide (with ritonavir), propafenone (with ritonavir) o Antimycobacterial: Rifampin o Antipsychotic: Lurasidone (with ritonavir), pimozide o Ergot derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine o GI motility agent: Cisapride o Herbal product: St. John's wort ( Hypericum perforatum o Lipid modifying agents: Lomitapide, lovastatin, simvastatin o Non-nucleoside reverse transcriptase inhibitor: Delavirdine o PDE5 inhibitor: Sildenafil (REVATIO) (for treatment of pulmonary arterial hypertension) o Sedative/hypnotics: Midazolam, triazolam * 4 * 4 * 4" http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00701 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#provenance http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#pubinfo http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#sig http://purl.org/nanopub/x/hasSignature KbmORKHgOhdE4yYyClv95x8Ra0oBPSaXPdTeZSYXns62laEFVYQX9M+SArGkgBvk9+wS/lBE2zfQuRRy+6/B8wOuW02F/U6FEJ1IlLlqWoxxK6Qiz3digzHoCV17AExW38CW827p/CluSJpEd9FwzxM2z5c30UxA8/kS9PpRp6k= http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik http://purl.org/dc/terms/created 2021-08-23T18:36:07.853+02:00 http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY